FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15600711000001107: Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
54970601000001114 Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64112501000001117 Mapemid XL 1.5mg tablets (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Is a Indapamide 1.5mg modified-release tablets true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Is a Indapamide 1.5mg m/r tablet false Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has active ingredient Indapamide true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Is a Mapemid XL true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has specific active ingredient Indapamide true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Is a Indapamide 1.5mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) 30 tablet 2 x 15 tablets Has AMP True Mapemid XL 1.5mg tablets (Ratiopharm UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start